GlassScriptPhysician profile
Monica Green
NPI 1821351321
$1,455.03
in general payments reported to CMS, 2019-2025
17 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $361 · 2023: $416 · 2024: $384 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $474.30 | 2021-2025 | Caplyta |
| Abbvie INC. | $222.19 | 2021-2025 | |
| Alkermes, INC. | $125.51 | 2023-2024 | Aristada, Lybalvi |
| Axsome Therapeutics, INC. | $112.85 | 2023-2024 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.96 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $87.94 | 2022-2023 | Rexulti, Abilify Maintena |
| Corium, LLC | $73.47 | 2023-2025 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $52.60 | 2022 | |
| Glaxosmithkline, LLC. | $37.56 | 2022 | |
| Ironshore Pharmaceuticals INC. | $34.21 | 2022-2024 | |
| Organon LLC | $25.18 | 2023 | Nexplanon |
| Vanda Pharmaceuticals INC. | $21.81 | 2021 | |
| Lilly USA, LLC | $21.73 | 2024 | Mounjaro, Zepbound |
| Collegium Pharmaceutical, INC. | $18.88 | 2025 | Jornay Pm |
| Lundbeck LLC | $17.46 | 2025 | Rexulti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17.28 | 2021 | |
| Novo Nordisk INC | $14.10 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.